Citations (87)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Selina Ackermann, Anette Heierle, Martina-Barbara Bingisser, Ralph Hertwig, Rakesh Padiyath, Christian Hans Nickel, Wolf Langewitz & Roland Bingisser. (2016) Discharge Communication in Patients Presenting to the Emergency Department With Chest Pain: Defining the Ideal Content. Health Communication 31:5, pages 557-565.
Read now
Read now
David M. Kern, Carl Mellström, Phillip R. Hunt, Ozgur Tunceli, Bingcao Wu, Mogens Westergaard & Niklas Hammar. (2016) Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population. Current Medical Research and Opinion 32:4, pages 703-711.
Read now
Read now
William H. Olson, Yi-Wen Ma, Concetta Crivera, Jeff Schein, Patrick Lefebvre, François Laliberté, Katherine Dea, Guillaume Germain & Scott M. Lynch. (2015) Economic outcomes with prasugrel versus clopidogrel in acute coronary syndrome patients: observations from prasugrel users and matched clopidogrel users. Journal of Medical Economics 18:12, pages 1074-1084.
Read now
Read now
Cliff Molife, Feride Frech-Tamas, Mitch DeKoven, Mark B. Effron, Swapna Karkare, Yajun Zhu, Cynthia Larmore, Jingsong Lu, Patrick McCollam, Elizabeth Marrett & George W. Vetrovec. (2015) Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelor. Journal of Medical Economics 18:11, pages 898-908.
Read now
Read now
Shih-Yin Chen, Concetta Crivera, Michael Stokes, Luke Boulanger & Jeffrey Schein. (2013) Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population. ClinicoEconomics and Outcomes Research 5, pages 181-188.
Read now
Read now
Robert Lee Page$suffix/text()$suffix/text(), Vahram Ghushchyan, Richard R Allen, Lisa Roper, Don Beck, Bamrom H Jonathan, Feride Frech-Tamas, Wing Chan, R Brett McQueen & Kavita V Nair. (2012) Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap. Drug, Healthcare and Patient Safety 4, pages 67-74.
Read now
Read now
Zhenxiang Zhao, Baojin Zhu, Johnna Anderson, Haoda Fu & LeRoy LeNarz. (2010) Resource utilization and healthcare costs for acute coronary syndrome patients with and without diabetes mellitus. Journal of Medical Economics 13:4, pages 748-759.
Read now
Read now
Karina Berenson, Augustina Ogbonnaya, Roman Casciano, Dinara Makenbaeva, Essy Mozaffari, Lois Lamerato & John Corbelli. (2010) Economic consequences of ACS-related rehospitalizations in the US. Current Medical Research and Opinion 26:2, pages 329-336.
Read now
Read now
Articles from other publishers (79)
Gregory A. Nichols, Efrat L. Amitay, Satabdi Chatterjee & Dominik Steubl. (2023) Health Care Costs Associated with the Development and Combination of Cardio-Renal-Metabolic Diseases. Kidney360 4:10, pages 1382-1388.
Crossref
Crossref
Ciarán Stanley, David Lennon, Frank Moriarty, Gerard A. Sheridan, Matthew Nagle, Alexandra Foley, Conor Moran & Michael Donnelly. (2023) The association between weather warnings and hip fractures in the Republic of Ireland. Archives of Osteoporosis 18:1.
Crossref
Crossref
Cheng Chen, Shin-Yi Chou, Hsien-Ming Lien & Jin-Tan Liu. (2023) The Long-Term Health Effects of Early-Life Malaria Exposure: Evidence from Taiwan's Malaria Eradication in the 1950s. American Journal of Health Economics.
Crossref
Crossref
Cuihong Tian, Zhaowei Zhu, Hebin Xie, Cheng Wei, Zhenfei Fang, Xinqun Hu & Shenghua Zhou. (2023) Association between Percentage of Neutrophils at Admission and in-Hospital Events in Patients ≥75 Years of Age with Acute Coronary Syndrome. Cardiovascular Innovations and Applications 7:1.
Crossref
Crossref
Himanshu S. Sahoo, Nicholas E. Ingraham, Greg M. Silverman & John M. Sartori. (2022) Towards Fairness and Interpretability: Clinical Decision Support for Acute Coronary Syndrome. Towards Fairness and Interpretability: Clinical Decision Support for Acute Coronary Syndrome.
Abdulrahman Ismaiel, Mohammad Zeeshan Ashfaq, Daniel-Corneliu Leucuta, Mohamed Ismaiel, Dilara Ensar Ismaiel, Stefan-Lucian Popa & Dan L Dumitrascu. (2022) Chemerin Levels in Acute Coronary Syndrome: Systematic Review and Meta-Analysis. Laboratory Medicine 53:6, pages 552-560.
Crossref
Crossref
Arun Surendran, Negar Atefi, Hannah Zhang, Michel Aliani & Amir Ravandi. (2021) Defining Acute Coronary Syndrome through Metabolomics. Metabolites 11:10, pages 685.
Crossref
Crossref
José C. Nicolau, David Brieger, Ruth Owen, Remo H.M. Furtado, Shaun G. Goodman, Mauricio G. Cohen, Tabassome Simon, Dirk Westermann, Christopher B. Granger, Richard Grieve, Satoshi Yasuda, Jiyan Chen, Katarina Hedman, Carl Mellström, Gunnar Brandrup‐Wognsen & Stuart J. Pocock. (2020) Diabetes association with self‐reported health, resource utilization, and prognosis post‐myocardial infarction. Clinical Cardiology 43:12, pages 1352-1361.
Crossref
Crossref
Răzvan-Andrei Licu, Emanuel Blîndu, Diana Opincariu & Theodora Benedek. (2020) Vulnerable Plaques Producing an Acute Coronary Syndrome Exhibit a Different CT Phenotype than Those That Remain Silent. Journal Of Cardiovascular Emergencies 6:2, pages 26-34.
Crossref
Crossref
Iván Quevedo, Juan C. Ormeño, Bunio Weissglas & Cristóbal Opazo. (2020) Epidemiology and Direct Medical Cost of Osteoporotic Hip Fracture in Chile. Journal of Osteoporosis 2020, pages 1-7.
Crossref
Crossref
Fadhaa A. Ghafil, Bassim I. Mohammad, Hussain S. Al-Janabi, Najah R. Hadi & Hayder A. Al-Aubaidy. (2020) Genetic polymorphism of angiotensin converting enzyme and angiotensin II type 1 receptors and their impact on the outcome of acute coronary syndrome. Genomics 112:1, pages 867-872.
Crossref
Crossref
Stuart J Pocock, Yong Huo, Frans Van de Werf, Simon Newsome, Chee Tang Chin, Ana Maria Vega, Jesús Medina & Héctor Bueno. (2017) Predicting two-year mortality from discharge after acute coronary syndrome: An internationally-based risk score. European Heart Journal: Acute Cardiovascular Care 8:8, pages 727-737.
Crossref
Crossref
Laura Pirhonen, Kristian Bolin, Elisabeth Hansson Olofsson, Andreas Fors, Inger Ekman, Karl Swedberg & Hanna Gyllensten. (2019) Person-Centred Care in Patients with Acute Coronary Syndrome: Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial. PharmacoEconomics - Open 3:4, pages 495-504.
Crossref
Crossref
Huimin Xu, Jie Zou, Xiaoli Ye, Jiayun Han, Lan Gao, Shunbin Luo, Jingling Wang, Chunyan Huang, Xiaofeng Yan & Haibin Dai. (2019) Impacts of Clinical Pharmacist Intervention on the Secondary Prevention of Coronary Heart Disease: A Randomized Controlled Clinical Study. Frontiers in Pharmacology 10.
Crossref
Crossref
Andrea T. Duran, Carol Ewing Garber, Talea Cornelius, Joseph E. Schwartz & Keith M. Diaz. (2019) Patterns of Sedentary Behavior in the First Month After Acute Coronary Syndrome. Journal of the American Heart Association 8:15.
Crossref
Crossref
Zhao Ni, Latefa Dardas, Bei Wu & Ryan Shaw. (2019) Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review. Heart Asia 11:2, pages e011173.
Crossref
Crossref
Kim G. Smolderen, Anna Brush & Rachel P. Dreyer. (2019) Psychosocial Factors and Recovery After Acute Myocardial Infarction in Younger Women. Current Cardiology Reports 21:6.
Crossref
Crossref
Samuel K. Peasah, Martin I. Meltzer, Michelle Vu, Danielle L. Moulia & Carolyn B. Bridges. (2019) Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US. PLOS ONE 14:4, pages e0213499.
Crossref
Crossref
Xavier Rossello, Héctor Bueno, Stuart J Pocock, Frans Van de Werf, Nicolas Danchin, Lieven Annemans, Jesús Medina & Uwe Zeymer. (2018) Predictors of all‐cause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: Results from the EPICOR registry. Clinical Cardiology 42:1, pages 111-119.
Crossref
Crossref
Kibum KimTodd A. LeeDaniel R. TouchetteRobert J. DiDomenicoAmer K. ArdatiSurrey M. Walton. (2018) Comparison of 6-Month Costs Between Oral Antiplatelet Agents Following Acute Coronary Syndrome. Journal of Managed Care & Specialty Pharmacy 24:8, pages 800-812.
Crossref
Crossref
Jamie JarmulMark J. PletcherKristen Hassmiller LichStephanie B. WheelerMorris WeinbergerChristy L. AveryDaniel E. JonasStephanie EarnshawMichael Pignone. (2018) Cardiovascular Genetic Risk Testing for Targeting Statin Therapy in the Primary Prevention of Atherosclerotic Cardiovascular Disease. Circulation: Cardiovascular Quality and Outcomes 11:4.
Crossref
Crossref
Jung-Min Ahn. (2018) Health Promoting Life Style after Coronary Stenting: Underuse of Proven Therapy. Korean Circulation Journal 48:6, pages 516.
Crossref
Crossref
S. Williamson, F. Landeiro, T. McConnell, L. Fulford-Smith, M. K. Javaid, A. Judge & J. Leal. (2017) Costs of fragility hip fractures globally: a systematic review and meta-regression analysis. Osteoporosis International 28:10, pages 2791-2800.
Crossref
Crossref
Minghuan Jiang & Joyce H.S. You. (2017) Cost-effectiveness analysis of 30-month vs 12-month dual antiplatelet therapy with clopidogrel and aspirin after drug-eluting stents in patients with acute coronary syndrome. Clinical Cardiology 40:10, pages 789-796.
Crossref
Crossref
Kibum Kim, Todd A. Lee, Amer K. Ardati, Robert J. DiDomenico, Daniel R. Touchette & Surrey M. Walton. (2017) Comparative Effectiveness of Oral Antiplatelet Agents in Patients with Acute Coronary Syndrome. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37:8, pages 877-887.
Crossref
Crossref
Mehul D. PatelDavid WuMonica Reed ChasePanagiotis MavrosKim HeithoffMary E. HansonRoss J. SimpsonJr.Jr.. (2017) Antiplatelet Therapy and Clinical Outcomes Following Myocardial Infarction Among Patients in a U.S. Employer-Based Insurance Database. Journal of Managed Care & Specialty Pharmacy 23:6, pages 684-690.
Crossref
Crossref
Krista F. Huybrechts, Rishi J. Desai, Moa Park, Joshua J. Gagne, Mehdi Najafzadeh & Jerry Avorn. (2017) The Potential Return on Public Investment in Detecting Adverse Drug Effects. Medical Care 55:6, pages 545-551.
Crossref
Crossref
Chin-Lan Chen, David H.-T. Yen, Chin-Sheng Lin, Shih-Hung Tsai, Sy-Jou Chen, Wayne H.-H. Sheu & Chin-Wang Hsu. (2017) Glycated hemoglobin level is an independent predictor of major adverse cardiac events after nonfatal acute myocardial infarction in nondiabetic patients. Medicine 96:18, pages e6743.
Crossref
Crossref
Stephanie R. Earnshaw, Cheryl L. McDade, YiFang Chu, Lisa E. Fleige & John L. Sievenpiper. (2017) Cost-effectiveness of Maintaining Daily Intake of Oat β-Glucan for Coronary Heart Disease Primary Prevention. Clinical Therapeutics 39:4, pages 804-818.e3.
Crossref
Crossref
Minghuan Jiang & Joyce H. S. You. (2016) CYP2C19 LOF and GOF-Guided Antiplatelet Therapy in Patients with Acute Coronary Syndrome: A Cost-Effectiveness Analysis. Cardiovascular Drugs and Therapy 31:1, pages 39-49.
Crossref
Crossref
Li Yang, Yifei Liu, Liankui Wen & Jingjing Wu. (2016) Examining the Impact of Rehospitalization on Healthcare Cost of Myocardial Infarction Patients in Beijing: A Retrospective Observational Study. Advances in Therapy 34:1, pages 109-119.
Crossref
Crossref
Zhuyuan Liu, Huanyu Gu, Qiying Dai, Hongbao Wang, Jianhua Yao & Lei Zhou. 2017. Exercise for Cardiovascular Disease Prevention and Treatment. Exercise for Cardiovascular Disease Prevention and Treatment
9
29
.
Min Meng, Bei Gao, Xia Wang, Zheng-gang Bai, Ri-na Sa & Bin Ge. (2016) Long-term clinical outcomes of everolimus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: a meta-analysis. BMC Cardiovascular Disorders 16:1.
Crossref
Crossref
Jeff C. Huffman, Rachel A. Millstein, Carol A. Mastromauro, Shannon V. Moore, Christopher M. Celano, C. Andres Bedoya, Laura Suarez, Julia K. Boehm & James L. Januzzi. (2015) A Positive Psychology Intervention for Patients with an Acute Coronary Syndrome: Treatment Development and Proof-of-Concept Trial. Journal of Happiness Studies 17:5, pages 1985-2006.
Crossref
Crossref
Jeff C Huffman, Christina M DuBois, Carol A Mastromauro, Shannon V Moore, Laura Suarez & Elyse R Park. (2014) Positive psychological states and health behaviors in acute coronary syndrome patients: A qualitative study. Journal of Health Psychology 21:6, pages 1026-1036.
Crossref
Crossref
Li-Juan Yi, Xu Tian, Ting Shuai, Zi Zeng, Li Ma, Yan Wang & Guo-Min Song. (2016) Case management does not decrease mortality of patients with myocardial infarction or unstable angina: Evidence from a systematic review. International Journal of Nursing Sciences 3:2, pages 190-197.
Crossref
Crossref
Minghuan Jiang & Joyce HS You. (2016) Cost–effectiveness analysis of personalized antiplatelet therapy in patients with acute coronary syndrome. Pharmacogenomics 17:7, pages 701-713.
Crossref
Crossref
Jeff C. HuffmanEleanor E. BealeChristopher M. CelanoScott R. BeachArianna M. BelcherShannon V. MooreLaura SuarezShweta R. MotiwalaParul U. GandhiHanna K. GagginJames L. Januzzi. (2016) Effects of Optimism and Gratitude on Physical Activity, Biomarkers, and Readmissions After an Acute Coronary Syndrome. Circulation: Cardiovascular Quality and Outcomes 9:1, pages 55-63.
Crossref
Crossref
Bob J.H. van Kempen, Bart S. Ferket, Ewout W. Steyerberg, Wendy Max, M.G. Myriam Hunink & Kirsten E. Fleischmann. (2016) Comparing the cost-effectiveness of four novel risk markers for screening asymptomatic individuals to prevent cardiovascular disease (CVD) in the US population. International Journal of Cardiology 203, pages 422-431.
Crossref
Crossref
Minghuan Jiang & Joyce H.S. You. (2015) CYP2C19 genotype plus platelet reactivity-guided antiplatelet therapy in acute coronary syndrome patients. Pharmacogenetics and Genomics 25:12, pages 609-617.
Crossref
Crossref
Susan D. Housholder-Hughes, Michael J. Ranella, Abiola Dele-Michael & Melvyn Rubenfire. (2015) Evaluation of a postdischarge coronary artery disease management program. Journal of the American Association of Nurse Practitioners 27:7, pages 371-378.
Crossref
Crossref
Nader Makki, Theresa M. Brennan & Saket Girotra. (2013) Acute Coronary Syndrome. Journal of Intensive Care Medicine 30:4, pages 186-200.
Crossref
Crossref
Guijing WangHeesoo JooXin TongMary G. George. (2015) Hospital Costs Associated With Atrial Fibrillation for Patients With Ischemic Stroke Aged 18–64 Years in the United States. Stroke 46:5, pages 1314-1320.
Crossref
Crossref
R.J.G. Peters. (2015) Guidance on guideline adherence. Netherlands Heart Journal 23:4, pages 212-213.
Crossref
Crossref
Taulant Muka, David Imo, Loes Jaspers, Veronica Colpani, Layal Chaker, Sven J. van der Lee, Shanthi Mendis, Rajiv Chowdhury, Wichor M. Bramer, Abby Falla, Raha Pazoki & Oscar H. Franco. (2015) The global impact of non-communicable diseases on healthcare spending and national income: a systematic review. European Journal of Epidemiology 30:4, pages 251-277.
Crossref
Crossref
F. Z. Abdullaev, V. Sh. Mamedov, I. M. Bagirov, I. D. Geybatov, L. S. Shikhieva & N. Dzh Kazimzade. (2015) Features of ischemic heart disease and myocardial revascularization in patients younger than 40 years. Kardiologiya i serdechno-sosudistaya khirurgiya 8:2, pages 21.
Crossref
Crossref
W. H. Olson, Y.-W. Ma, F. Laliberté, P. Lefebvre, C. Crivera, J. R. Schein, L. E. Fields, K. Dea, G. Germain & S. M. Lynch. (2014) Prasugrel vs. clopidogrel in acute coronary syndrome patients treated with prasugrel. Journal of Clinical Pharmacy and Therapeutics 39:6, pages 663-672.
Crossref
Crossref
Pedro Amariles, Héctor Holguín, Nancy Yaneth Angulo, Piedad Maria Betancourth & Mauricio Ceballos. (2014) Efecto de la interacción clopidogrel-omeprazol en el reingreso hospitalario de pacientes por recidiva de síndrome coronario agudo: estudio de casos y controles. Atención Primaria 46:8, pages 426-432.
Crossref
Crossref
Dan Atar, Christoph Bode, André Stuerzenbecher & Freek W. A. Verheugt. (2014) Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decade. Fundamental & Clinical Pharmacology 28:4, pages 353-363.
Crossref
Crossref
Guijing Wang, Zefeng Zhang, Carma Ayala, Diane O. Dunet, Jing Fang & Mary G. George. (2014) Costs of Hospitalization for Stroke Patients Aged 18-64 Years in the United States. Journal of Stroke and Cerebrovascular Diseases 23:5, pages 861-868.
Crossref
Crossref
Hui-min Xu, Hong-wen Cai, Hai-bin Dai, Xiao-feng Yan, Quan Zhou, Geng Xu, Zhao-quan Huang & Wei Mao. (2014) Use of evidence-based pharmacotherapy for secondary prevention of coronary heart disease: A Chinese medicine hospital versus a general hospital. Chinese Journal of Integrative Medicine 20:5, pages 375-380.
Crossref
Crossref
Hongwen Cai, Haibin Dai, Yangmin Hu, Xiaofeng Yan & Huimin Xu. (2013) Pharmacist care and the management of coronary heart disease: a systematic review of randomized controlled trials. BMC Health Services Research 13:1.
Crossref
Crossref
Jinhyun Kim, Eunhee Lee, Taejin Lee & Aeree Sohn. (2013) Economic burden of acute coronary syndrome in South Korea: a national survey. BMC Cardiovascular Disorders 13:1.
Crossref
Crossref
Henneke Versteeg, Madelein T. Hoogwegt, Tina B. Hansen, Susanne S. Pedersen, Ann-Dorthe Zwisler & Lau C. Thygesen. (2013) Depression, not anxiety, is independently associated with 5-year hospitalizations and mortality in patients with ischemic heart disease. Journal of Psychosomatic Research 75:6, pages 518-525.
Crossref
Crossref
Michael Pignone, Stephanie Earnshaw, Cheryl McDade & Mark J. Pletcher. (2013) Effect of Including Cancer Mortality on the Cost-Effectiveness of Aspirin for Primary Prevention in Men. Journal of General Internal Medicine 28:11, pages 1483-1491.
Crossref
Crossref
Paul P. Dobesh & Julie H. Oestreich. (2012) Novel Direct-Acting Anticoagulants for Risk Reduction in ACS. Journal of Pharmacy Practice 26:4, pages 358-366.
Crossref
Crossref
Nikos Maniadakis, Georgia Kourlaba, Dennis V. Cokkinos, Aggeliki Angeli & John Kyriopoulos. (2012) The economic burden of atherothrombosis in Greece: results from the THESIS study. The European Journal of Health Economics 14:4, pages 655-665.
Crossref
Crossref
Robert L. Page, Vahram Ghushchyan, Brian Gifford, Richard Allen Read, Monika Raut, Concetta Crivera, Ahmad B. Naim, C.V. Damaraju & Kavita V. Nair. (2013) The Economic Burden of Acute Coronary Syndromes for Employees and Their Dependents. Journal of Occupational & Environmental Medicine 55:7, pages 761-767.
Crossref
Crossref
J. Zeidler, A. Lange, S. Braun, R. Linder, S. Engel, F. Verheyen & J.-M. Graf von der Schulenburg. (2013) Die Berechnung indikationsspezifischer Kosten bei GKV-Routinedatenanalysen am Beispiel von ADHSCalculation of disease-related costs in claims data analyses with the example of attention-deficit hyperactivity disorder. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 56:3, pages 430-438.
Crossref
Crossref
William E. Boden, Alexandra Lansky & Dominick J. Angiolillo. (2013) Refining the Role of Antiplatelet Therapy in Medically Managed Patients With Acute Coronary Syndrome. The American Journal of Cardiology 111:3, pages 439-444.
Crossref
Crossref
Eric S Meadows, Jay P Bae, Anthony Zagar, Tomoko Sugihara, Krishnan Ramaswamy, Rebecca McCracken & Darell Heiselman. (2012) Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis. BMC Research Notes 5:1.
Crossref
Crossref
Neil Oldridge. (2012) Exercise-based cardiac rehabilitation in patients with coronary heart disease: meta-analysis outcomes revisited. Future Cardiology 8:5, pages 729-751.
Crossref
Crossref
Philip J. Dougherty & Rohit R. Arora. (2012) Utility of Early High Dose Statins in Acute Coronary Syndrome. American Journal of Therapeutics 19:5, pages 369-376.
Crossref
Crossref
Donald Edmondson, Safiya Richardson, Louise Falzon, Karina W. Davidson, Mary Alice Mills & Yuval Neria. (2012) Posttraumatic Stress Disorder Prevalence and Risk of Recurrence in Acute Coronary Syndrome Patients: A Meta-analytic Review. PLoS ONE 7:6, pages e38915.
Crossref
Crossref
AMEET BAKHAI, JEAN FERRIERES, ANDRES IÑIGUEZ, MAGALI SARTRAL, MARK BELGER, CLAUDE SCHMITT & UWE ZEYMER. (2011) Clinical Outcomes, Resource Use, and Costs at 1 Year in Patients with Acute Coronary Syndrome Undergoing PCI: Results from the Multinational APTOR Registry. Journal of Interventional Cardiology 25:1, pages 19-27.
Crossref
Crossref
Christian W. Hamm, Jean-Pierre Bassand, Stefan Agewall, Jeroen Bax, Eric Boersma, Hector Bueno, Pio Caso, Dariusz Dudek, Stephan Gielen, Kurt Huber, Magnus Ohman, Mark C. Petrie, Frank Sonntag, Miguel Sousa Uva, Robert F. Storey, William Wijns & Doron Zahger. (2012) Guía de práctica clínica de la ESC para el manejo del síndrome coronario agudo en pacientes sin elevación persistente del segmento ST. Revista Española de Cardiología 65:2, pages 173.e1-173.e55.
Crossref
Crossref
Zhenxiang Zhao & Melissa Winget. (2011) Economic burden of illness of acute coronary syndromes: medical and productivity costs. BMC Health Services Research 11:1.
Crossref
Crossref
C. W. Hamm, J.-P. Bassand, S. Agewall, J. Bax, E. Boersma, H. Bueno, P. Caso, D. Dudek, S. Gielen, K. Huber, M. Ohman, M. C. Petrie, F. Sonntag, M. S. Uva, R. F. Storey, W. Wijns, D. Zahger, J. J. Bax, A. Auricchio, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, D. Poldermans, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, A. Torbicki, A. Vahanian, S. Windecker, S. Windecker, S. Achenbach, L. Badimon, M. Bertrand, H. E. Botker, J.-P. Collet, F. Crea, N. Danchin, E. Falk, J. Goudevenos, D. Gulba, R. Hambrecht, J. Herrmann, A. Kastrati, K. Kjeldsen, S. D. Kristensen, P. Lancellotti, J. Mehilli, B. Merkely, G. Montalescot, F.-J. Neumann, L. Neyses, J. Perk, M. Roffi, F. Romeo, M. Ruda, E. Swahn, M. Valgimigli, C. J. Vrints & P. Widimsky. (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal 32:23, pages 2999-3054.
Crossref
Crossref
Thomas Reinhold, Claudia Lindig, Stefan N. Willich & Bernd Brüggenjürgen. (2011) The costs of myocardial infarction—a longitudinal analysis using data from a large German health insurance company. Journal of Public Health 19:6, pages 579-586.
Crossref
Crossref
Rebecca L. ReeseKenneth E. FreedlandBrian C. SteinmeyerMichael W. RichJustin W. RackleyRobert M. Carney. (2011) Depression and Rehospitalization Following Acute Myocardial Infarction. Circulation: Cardiovascular Quality and Outcomes 4:6, pages 626-633.
Crossref
Crossref
Patrick R. Lawler, Kristian B. Filion & Mark J. Eisenberg. (2011) Efficacy of exercise-based cardiac rehabilitation post–myocardial infarction: A systematic review and meta-analysis of randomized controlled trials. American Heart Journal 162:4, pages 571-584.e2.
Crossref
Crossref
Lorenzo G. Mantovani, Carla Fornari, Fabiana Madotto, Michele A. Riva, Luca Merlino, Marco M. Ferrario, Virginio Chiodini, Alberto Zocchetti, Giovanni Corrao & Giancarlo Cesana. (2011) Burden of acute myocardial infarction. International Journal of Cardiology 150:1, pages 111-112.
Crossref
Crossref
Subha V. RamanGiuseppe Ambrosio. (2011) T2-Cardiac Magnetic Resonance. Circulation: Cardiovascular Imaging 4:3, pages 198-200.
Crossref
Crossref
Virginia L. Priest, Paul A. Scuffham, Rory Hachamovitch & Thomas H. Marwick. (2011) Cost-Effectiveness of Coronary Computed Tomography and Cardiac Stress Imaging in the Emergency Department. JACC: Cardiovascular Imaging 4:5, pages 549-556.
Crossref
Crossref
Stephen S. Johnston, Suellen Curkendall, Dinara Makenbaeva, Essy Mozaffari, Ron Goetzel, Wayne Burton & Ross Maclean. (2011) The Direct and Indirect Cost Burden of AcuteCoronary Syndrome. Journal of Occupational & Environmental Medicine 53:1, pages 2-7.
Crossref
Crossref
Kathleen Lang, Jonathan R. Korn, Robert J. Simko, Woodie M. Zachry, Nikil V. Patel, Radhika Nair & Joseph Menzin. (2010) Development of an Interactive Model of the Burden of Future Coronary Heart Disease From an Employer Perspective. Journal of Occupational & Environmental Medicine 52:9, pages 851-857.
Crossref
Crossref
Tomás Villanueva. (2010) Transitioning the patient with acute coronary syndrome from inpatient to primary care. Journal of Hospital Medicine 5:S4, pages S8-S14.
Crossref
Crossref
Neal B. PatelGary J. Balady. (2010) The Rewards of Good Behavior. Circulation 121:6, pages 733-735.
Crossref
Crossref
Shiori Amemiya & Hidemasa Takao. (2009) Computed Tomographic Coronary Angiography for Diagnosing Stable Coronary Artery Disease A Cost-Utility and Cost-Effectiveness Analysis. Circulation Journal 73:7, pages 1263-1270.
Crossref
Crossref